妇科癌症患者保留生育功能治疗:28部指南对比与分期路径整合
该综述对比了28部涉及子宫内膜癌、宫颈癌和卵巢癌保留生育功能管理的临床指南,整合诊断检查、入选阈值、手术方式和监测方案,形成分期特异性路径。指南对低风险早期病变的保留生育治疗共识广泛,但对更高分期和少见组织学类型的推荐不一致,且整体证据有限。将常规生育咨询和转诊嵌入标准化路径有助于在保障肿瘤安全的同时提升保留生育功能的实施。
要点
- 对符合条件的早期低风险妇科癌症患者,多部指南支持保留生育功能治疗。
- 更高分期和少见组织学类型的保留生育推荐在各指南间不一致。
- 应将常规生育咨询和转诊嵌入标准化诊疗路径。
核心结论
- 多部独立指南广泛同意对经过严格选择的特定早期低风险妇科癌症患者实施保留生育功能治疗。
- 更高分期疾病和少见组织学类型的推荐存在分歧且不一致。
- 将常规生育咨询和转诊嵌入标准化路径是改善实施的重要步骤。
研究设计与样本
- 综述对比了28部涉及子宫内膜癌、宫颈癌和卵巢癌保留生育功能管理的临床指南。
- 汇总了诊断检查、入选阈值、手术方式和监测方案,并整合为分期特异性路径。
主要发现
- 指南广泛同意支持保留生育治疗的情况包括:1级IA期子宫内膜样癌;无高危特征且小于2 cm的IA1-IB1期宫颈肿瘤;交界性卵巢肿瘤和大多数恶性生殖细胞肿瘤。
- 更高分期疾病和少见组织学类型的推荐不一致。
- 整体指南质量为中等至高等,但在早期低风险病变之外常依赖有限证据或专家意见。
关键数值与推荐
- 1级IA期子宫内膜样子宫内膜癌可考虑保留生育功能治疗。
- 无高危特征且测量小于2 cm的IA1-IB1期宫颈肿瘤可考虑保留生育功能治疗。
- 交界性卵巢肿瘤和大多数恶性生殖细胞肿瘤可考虑保留生育功能治疗。
临床怎么用
- 按分期特异性路径对早期低风险妇科癌症患者评估保留生育功能治疗的适用性。
- 将常规生育咨询和转诊嵌入标准化诊疗路径以提升实施率。
- 对更高分期或少见组织学类型患者,需注意指南推荐不一致并个体化决策。
局限性
- 整体指南在早期低风险病变之外常依赖有限证据或专家意见。
- 更高分期和少见组织学类型的推荐不一致,存在证据缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fertility preservation is a critical consideration in the care of reproductive-aged patients with gynecologic cancers, yet referral to reproductive specialists remains low, indicating a gap between guidance and practice. We compared 28 clinical guidelines that addressed fertility-sparing management of endometrial, cervical, and ovarian cancers, and reviewed diagnostic workup, eligibility thresholds, surgical approaches, and surveillance protocols. Recommendations were synthesized into stage-specific pathways to delineate areas of consensus, highlight discrepancies, and map evidence gaps. There is broad agreement across multiple independent guidelines to support fertility-sparing treatment for carefully selected patients with: grade 1, stage IA endometrioid endometrial carcinoma; stage IA1-IB1 cervical tumors measuring less than 2 cm without high-risk features; and borderline ovarian tumors and most malignant germ cell tumors. Recommendations for higher stage disease and uncommon histologies, however, diverge and remain inconsistent. Overall guideline quality was moderate to high but frequently relied on limited evidence or expert opinion outside early-stage, low-risk conditions. Synthesizing current guidance clarifies areas where practice can be standardized and prospective data are needed. Embedding routine fertility counseling and referral into standardized pathways is an important step to improve uptake while maintaining oncologic safety and preserving fertility potential.
引用
- Erden M, Rehman S, Oh C, et al. Fertility-Sparing Treatments in Patients With Gynecologic Cancers. Obstet Gynecol. 2025. PMID: 41343835. doi:10.1097/AOG.0000000000006141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。